Alibaba Health Information Technology (FRA:TWYA) ROCE %: 9.70% (As of Mar. 2026)


FRA:TWYA Alibaba Health Information Technology Ltd FRA:TWYA
83 GF Score
Price €5.90
GF Value €9.99
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Alibaba Health Information Technology ROCE %?

Alibaba Health Information Technology FRA:TWYA -3.28% 83 ROCE % is 9.70% as of Mar. 2026. GuruFocus rates FRA:TWYA with a GF Score™ of 83/100 and a GF Value™ of €9.99 (Significantly Undervalued). The stock has 2 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Alibaba Health Information Technology's annualized ROCE % for the quarter that ended in Mar. 2026 was 9.70%.

Alibaba Health Information Technology  (FRA:TWYA) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Alibaba Health Information Technology ROCE % Related Terms

Alibaba Health Information Technology ROCE % Historical Data

* Premium members only.

The historical data trend for Alibaba Health Information Technology's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alibaba Health Information Technology ROCE % Chart

Alibaba Health Information Technology Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.82 3.65 6.11 10.04 13.11

Alibaba Health Information Technology Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.96 10.92 9.31 16.22 9.70
FRA:TWYA
83GF Score
Alibaba Health Information Technology Ltd FRA:TWYA
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alibaba Health Information Technology ROCE % Calculation

Alibaba Health Information Technology's annualized ROCE % for the fiscal year that ended in Mar. 2026 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=285.604/( ( (2702.335 - 605.094) + (2898.324 - 639.237) )/ 2 )
=285.604/( (2097.241+2259.087)/ 2 )
=285.604/2178.164
=13.11 %

Alibaba Health Information Technology's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Sep. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Sep. 2025 )(Q: Mar. 2026 )
=212.276/( ( (2782.537 - 662.753) + (2898.324 - 639.237) )/ 2 )
=212.276/( ( 2119.784 + 2259.087 )/ 2 )
=212.276/2189.4355
=9.70 %

(1) Note: The EBIT data used here is two times the semi-annual (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 9.70% mean?
Alibaba Health Information Technology (FRA:TWYA) has a ROCE % of 9.70% as of Mar. 2026.
Is Alibaba Health Information Technology's ROCE % too high?
Alibaba Health Information Technology's current ROCE % is 9.70%. The Healthcare Providers & Services industry median ROCE % is 6.41. Alibaba Health Information Technology's value of 9.70% is 51.3% above this industry median. Overall, Alibaba Health Information Technology has a GF Score™ of 83/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Alibaba Health Information Technology's ROCE % compare to competitors?
Alibaba Health Information Technology's ROCE % of 9.70% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.41. Alibaba Health Information Technology's value of 9.70% is 51.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Providers & Services company?
The median ROCE % among Healthcare Providers & Services companies is 6.41, based on 648 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Alibaba Health Information Technology's current ROCE % of 9.70% is 51.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alibaba Health Information Technology's current ROCE % is 9.70%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alibaba Health Information Technology stock overvalued right now?
Based on GuruFocus' analysis, Alibaba Health Information Technology (FRA:TWYA) is currently considered Significantly Undervalued. The stock's GF Value™ is €9.99, compared to a current price of €5.90 — trading 40.9% below its estimated fair value. The current ROCE % is 9.70% and 51.3% above the Healthcare Providers & Services industry median of 6.41. Alibaba Health Information Technology's overall GF Score™ is 83/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Alibaba Health Information Technology (FRA:TWYA), the current ROCE % is 9.70% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Alibaba Health Information Technology (FRA:TWYA) Overvalued in 2026?

Based on GuruFocus' analysis, Alibaba Health Information Technology stock appears to be undervalued. The current stock price of €5.90 is trading 40.9% below its estimated GF Value™ of €9.99. GuruFocus considers Alibaba Health Information Technology to be Significantly Undervalued.

Key valuation signals for FRA:TWYA:

  • ROCE %: 9.70%
  • GF Value™: €9.99 vs. price of €5.90 (40.9% below fair value)
  • GF Score™: 83/100 with 2 warning signs
  • Industry Position: 51.3% above the Healthcare Providers & Services median

No single metric tells the full story. See the FRA:TWYA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Alibaba Health Information Technology Business Description

Address Wangjing East Park, 30th Floor, Greenland Center, Building 9, Zone 4, Chaoyang District, Beijing, CHN
Alibaba Health is of one of China's leading e-commerce platform specializing in healthcare-related products, including prescription drugs, OTC drugs, traditional Chinese medicine, health foods, and so on. The company operates both a third-party B2C service, or 3P, and its own direct-to-consumer business, or 1P, with its own inventory, which can both be accessed by Alibaba's Tmall app and Alipay. The company also provides online consultation services in a separate app although its e-commerce businesses remain its core competency in the long-term. E-commerce accounted for 93% of revenue in fiscal year 2022. We estimate that AliHealth holds about 45% of market share in the industry in terms of GMV. AliHealth is 63.74% owned by its parent company, Alibaba Group.
83GF Score

Get the complete analysis for FRA:TWYA

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€5.90
Price
€9.99
GF Value